Pfizer’s Beqvez gets FDA approval for adults with haemophilia B

By NS Healthcare Staff Writer 29 Apr 2024

The approval was based on the results from the Phase 3 BENEGENE-2 study in which Beqvez demonstrated non-inferiority against current standard of care

Pharmaceuticals

Pfizer’s Beqvez gets FDA approval for adults with haemophilia B

Advent International to invest $300m in India’s Apollo....

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to....

Bristol Myers Squibb to lay off 2,200 jobs....

Perrigo to divest HRA Pharma Rare Diseases business....

Pharmaceuticals

Regeneron and Mammoth collaborate on gene editing therapies
26 Apr 24

Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
26 Apr 24

Moderna expands collaboration with OpenAI to boost mRNA therapeutics
25 Apr 24

Patient Care

FDA approves Freedom Biosciences’ IND for FREE001 in TRD patients
26 Apr 24

Jemperli gets FDA priority review for expanded indication in endometrial cancer
25 Apr 24

FDA authorises Utility Therapeutics’ Pivya tablets for UTIs
25 Apr 24

Nutraceuticals

Nestlé India and Dr. Reddy’s to form joint venture to take health science nutraceutical portfolio to consumers across India and other agreed territories
26 Apr 24

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects
05 Apr 24

Arla Foods announces plans to become major UK exporter of mozzarella
05 Apr 24

NS Healthcare is using cookies

Regeneron and Mammoth collaborate on gene editing therapies26 Apr 24

Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing26 Apr 24

Moderna expands collaboration with OpenAI to boost mRNA therapeutics25 Apr 24

FDA approves Freedom Biosciences’ IND for FREE001 in TRD patients 26 Apr 24

Jemperli gets FDA priority review for expanded indication in endometrial cancer 25 Apr 24

FDA authorises Utility Therapeutics’ Pivya tablets for UTIs 25 Apr 24

Nestlé India and Dr. Reddy’s to form joint venture to take health science nutraceutical portfolio to consumers across India and other agreed territories26 Apr 24

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects05 Apr 24

Arla Foods announces plans to become major UK exporter of mozzarella05 Apr 24

OUR TITLES

Revvity Unveils a New Era of....26 Apr 24

Oxford Properties starts work on Ionis....06 Dec 23

Healthpeak to merge with Physicians Realty....31 Oct 23

PepsiCo Beverage’s Sacramento-Based Electric Fleet Is....29 Sep 23

Incyte to acquire Escient Pharmaceuticals for....24 Apr 24

Lilly acquires new injectable medicine manufacturing....23 Apr 24

Genmab to acquire ADC developer ProfoundBio....03 Apr 24

Novo Nordisk to buy cardiovascular drugmaker....26 Mar 24

Neomorph, Novo Nordisk enter $1.46bn partnership....27 Feb 24

AbbVie, Tentarix partner to develop oncology....23 Feb 24

General Dynamics unit wins $2.5bn contract....14 Nov 23

SGC, HitGen collaborate on DEL technology....29 Sep 23

Regeneron and Mammoth collaborate on gene editing therapies
26 Apr 24

Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
26 Apr 24

Moderna expands collaboration with OpenAI to boost mRNA therapeutics
25 Apr 24

FDA approves Freedom Biosciences’ IND for FREE001 in TRD patients
26 Apr 24

Jemperli gets FDA priority review for expanded indication in endometrial cancer
25 Apr 24

FDA authorises Utility Therapeutics’ Pivya tablets for UTIs
25 Apr 24

Nestlé India and Dr. Reddy’s to form joint venture to take health science nutraceutical portfolio to consumers across India and other agreed territories
26 Apr 24

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects
05 Apr 24

Arla Foods announces plans to become major UK exporter of mozzarella
05 Apr 24

Revvity Unveils a New Era of....
26 Apr 24

Oxford Properties starts work on Ionis....
06 Dec 23

Healthpeak to merge with Physicians Realty....
31 Oct 23

PepsiCo Beverage’s Sacramento-Based Electric Fleet Is....
29 Sep 23

Incyte to acquire Escient Pharmaceuticals for....
24 Apr 24

Lilly acquires new injectable medicine manufacturing....
23 Apr 24

Genmab to acquire ADC developer ProfoundBio....
03 Apr 24

Novo Nordisk to buy cardiovascular drugmaker....
26 Mar 24

Neomorph, Novo Nordisk enter $1.46bn partnership....
27 Feb 24

AbbVie, Tentarix partner to develop oncology....
23 Feb 24

General Dynamics unit wins $2.5bn contract....
14 Nov 23

SGC, HitGen collaborate on DEL technology....
29 Sep 23